Table 6. Univariate and Multivariate analysis for focal PSMs.
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | ||
| Age | 1.001 | 0.971–1.032 | 0.961 | ||||
| BMI | 1.052 | 0.979–1.132 | 0.168 | ||||
| PSA | 2.721 | 1.748–4.235 | <0.001* | 2.374 | 1.482–3.803 | <0.001* | |
| NLR | 0.857 | 0.712–1.031 | 0.102 | ||||
| PLR | 0.998 | 0.995–1.002 | 0.359 | ||||
| LMR | 1.065 | 0.964–1.178 | 0.217 | ||||
| Prognostic nutritional index | 1.024 | 0.982–1.067 | 0.272 | ||||
| Biopsy Gleason sum (≥8 vs. <8) | 1.73 | 1.140–2.626 | 0.01* | 0.966 | 0.571–1.635 | 0.897 | |
| Perineural invasion | 2.452 | 1.482–4.057 | <0.001* | 2.349 | 1.381–3.995 | 0.002* | |
| SVI | 2.714 | 1.487–4.955 | 0.001* | 1.566 | 0.796–3.079 | 0.194 | |
| Pathologic Gleason sum (≥8 vs. <8) | 2.4 | 1.547–3.721 | <0.001* | 1.780 | 1.032–3.076 | 0.039 | |
*, statistically significant. BMI, body mass index; PSA, prostate specific antigen; NLR, neutrophil to lymphocyte ratio; PLR, platelets to lymphocyte ratio; LMR, lymphocyteto monocyte ratio; SVI, seminal vesicle invasion.